Results
2288
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
2,288 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AV1 | AU$0.075 | 10.3% | 56.3% | AU$59.2m | n/a | PS14.2x | E144.2% | n/a | Software | ||
7373 | JP¥1,561.00 | 6.1% | -28.4% | JP¥23.9b | JP¥4,600.00 | PE23.6x | E32.7% | 1.9% | Commercial Services | ||
YGG | ฿1.02 | -1.9% | -83.5% | ฿614.0m | ฿10.75 | PS2.2x | E85.5% | 26.3% | Media | ||
7096 | JP¥1,654.00 | 1.6% | -35.8% | JP¥16.9b | n/a | PE41x | E38.4% | n/a | Healthcare | ||
9218 | JP¥761.00 | -2.9% | -15.4% | JP¥7.9b | n/a | PE96.9x | E79.6% | n/a | Healthcare | ||
BBT | AU$0.18 | -5.3% | -16.3% | AU$101.1m | n/a | PS1.7x | E97.9% | n/a | Consumer Services | ||
MX1 | AU$0.07 | 29.6% | -41.7% | AU$40.7m | n/a | PS2.7x | E86.1% | n/a | Healthcare | ||
5038 | JP¥1,705.00 | -5.8% | -2.2% | JP¥25.6b | n/a | PE37.2x | E27.5% | 0.6% | Healthcare | ||
CUV | AU$14.30 | -3.4% | -4.0% | AU$716.0m | AU$29.17 | PE20.1x | E27.4% | 0.3% | Pharmaceuticals & Biotech | ||
A253590 | ₩11,200.00 | 29.8% | 186.4% | ₩475.5b | n/a | PE85.4x | E71.3% | 0.3% | Semiconductors | ||
A179900 | ₩22,800.00 | 11.8% | -19.3% | ₩360.7b | ₩60,000.00 | PS18.1x | E134.6% | 0% | Tech | ||
PLT | AU$0.78 | 10.6% | 129.4% | AU$136.8m | AU$1.30 | PS1.9x | E106.4% | n/a | Diversified Financials | ||
A337930 | ₩10,450.00 | 12.2% | 125.5% | ₩306.3b | ₩15,000.00 | PE20x | E48.7% | 1.1% | Consumer Durables | ||
3DA | AU$0.39 | 11.4% | 100.0% | AU$211.9m | n/a | PS456.8x | E59.4% | n/a | Capital Goods | ||
GGP | UK£0.071 | 14.1% | 16.4% | UK£361.4m | n/a | PB7.2x | E48.8% | n/a | Materials | ||
AFISH | NOK 48.00 | 2.1% | -46.4% | NOK 1.5b | NOK 81.00 | PS1.5x | E98.9% | n/a | Food, Beverage & Tobacco | ||
AGP | €7.04 | 5.1% | 60.4% | €121.9m | €12.75 | PE18x | E22.1% | n/a | Capital Goods | ||
ZVRA | US$7.31 | -8.9% | 47.5% | US$397.0m | US$20.50 | PS16.2x | E68.5% | n/a | Pharmaceuticals & Biotech | ||
RMDA | ج.م2.75 | 3.8% | 92.2% | ج.م4.1b | ج.م4.11 | PE18.2x | E30.2% | 2.4% | Pharmaceuticals & Biotech | ||
MBTN | CHF 1.59 | -3.2% | -99.4% | CHF 49.0m | CHF 6.03 | PB0.3x | E95.4% | n/a | Semiconductors | ||
LAVV3 | R$8.08 | -5.9% | 7.7% | R$1.6b | R$12.98 | PE5.8x | E21.1% | 3.5% | Real Estate Management and Development | ||
NEWBRY | SEK 3.30 | 11.5% | -8.1% | SEK 80.1m | SEK 8.00 | PS4.3x | E116.2% | n/a | Pharmaceuticals & Biotech | ||
MVW | NOK 9.95 | -2.5% | 25.9% | NOK 325.5m | NOK 12.20 | PS18.9x | E70.8% | n/a | Materials | ||
KEBNI B | SEK 1.23 | 9.1% | 4.4% | SEK 333.0m | SEK 2.20 | PS2.9x | E86.1% | n/a | Tech |